Your Ally Through Canine Hemangiosarcoma
THE PIONEERING RESOURCE HUB TO HELP YOU NAVIGATE YOUR DOG’S DIAGNOSIS
Recent Updates
A pilot study of OXC-101 in dogs with hemangiosarcoma
A pilot study of the oral drug OXC-101 was presented at the American Association for Cancer Research (AACR) Annual Meeting in April. The...
Boron Neutron Capture Therapy Targets HSA Cells
Canine hemangiosarcoma cells take up boron through LAT1, making them vulnerable to neutron irradiation.
Published on: May 17, 2026
What Ozonated Glycerin Can Do for Hemangiosarcoma
Over 300 injections, 50 patients, and even spleen regenerations. What dog owners should know.
Published on: May 10, 2026
New Lab Models Mimic HSA Progression from Primary Tumor to Metastasis
Organoids and xenografts reveal PLAAT3 as a key driver of invasion
Published on: April 4, 2026
A Guide to Safely Using Supplements for Canine Hemangiosarcoma
What every owner needs to know about safety, interactions, and working with your vet—before you buy a single bottle.
Published on: March 7, 2026
Metastatic Site as Prognostic Variable in Splenic HSA
Liver involvement remains the strongest negative prognostic indicator, but pulmonary and muscular metastases showed no significant impact on survival.
Published on: February 25, 2026
For Pet Owners
Hemangiosarcoma moves fast, and we want you to focus on caring for your dog, instead of exhausting research. We aim to provide all the information you need to make the best decisions for your pet confidently.
For Veterinarians
The next breakthrough is always just around the corner. We have compiled everything you need to stay up-to-date and continue providing the best care for your patients.
We’re proud to partner with
Behind this nonprofit organization are pet owners who have been personally affected by this cancer. We are fighting to reach the days when early detection, effective treatments, and the eradication of Hemangiosarcoma are a reality for all dogs and their families.
